Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Centenary celebrations of Faculty of Law reach a highlight
2009-11-19

At the occasion were, from the left: the Honourable Judge Ian van der Merwe; the Honorable Judge Faan Hancke; former Judge of Appeal Joos Hefer; and Prof. Johan Henning, Dean of the Faculty of Law at the UFS.
Photo: Stephen Collett


The Faculty of Law at the University of the Free State (UFS) reached the highlight of its celebrations of a century of excellence in legal education, training and research under the theme “Iurisprudentia 100” at a gala dinner held on the Main Campus in Bloemfontein last week.

At this spectacular occasion Prof. Johan Henning, Dean of the Faculty handed a Cum Laude award to Judge Faan Hancke, Chairperson of the UFS Council and Extraordinary Professor in the Department of Law of Procedure and Law of Evidence. Judge Hancke is the fourth recipient of this award. Judge Hancke received the award for his excellent contributions towards the building of the Faculty of Law and the UFS.

According to Prof. Henning the faculty has a distinguished history of excellence in theoretical as well as practical education and training, which can be traced as far back as to the establishment of the Grey University College in 1904. During this modest beginning the seed was planted for the establishment of the Faculty of Law, which gained momentum when Bloemfontein became the judicial capital of South Africa in 1910.

Other highlights in legal education at the UFS include, amongst others, 1909 when Adv. Percy Fisher, a BA LLB graduate from the University of Cambridge became the first law lecturer to receive a permanent appointment. In 1918 the first LLB degrees were awarded to SP le Roux, later Minister of Agriculture, CR Swart, later Minister of Justice, Governor-General, State President and the first Chancellor of the UFS, and Walther Leinberger, an attorney in town.

In 1945 Law became an independent faculty and in 1948 the first full-time professor, Dr JP Verloren van Themaat was appointed. After Prof. Van Themaat, six deans followed before the appointment of Prof. Henning.

Over the last ten years the faculty has managed to build many international contacts with international leaders in the legal arena, including the Universities of London, Cambridge, Sussex, Tilburg, Kentucky, Heidelberg, Freiburg, Utrecht and Deacon.

The faculty prides itself on the fact that he has prepared many students as well as lecturers who later became presidents, ministers, administrators, judges of appeal, judges and rectors. The faculty has 95 staff members and 2 400 students, of which 1 800 are postgraduate students.

National as well as international leaders in the legal field congratulated the faculty on its 100-year celebrations. Messages of congratulations were also received from, amongst others, universities, legal practices and the government.

Media release
Issued by: Lacea Loader
Deputy Director: Media Liaison
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: loaderl.stg@ufs.ac.za  
18 November 2009
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept